• #10 Telehealth Regulations, Opioids, and Substance Use Treatment

  • 2022/09/30
  • 再生時間： 31 分
  • ポッドキャスト

#10 Telehealth Regulations, Opioids, and Substance Use Treatment

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Continued access to telehealth services, particularly as it relates to medication assisted treatment (MAT) for substance use disorders (SUDs), enjoys strong support and is an issue worth keeping an eye on. Nate Lacktman and Sunny Levine of the prestigious law firm of Foley & Lardner discuss the current state of telehealth regulations in the wake of COVID-19, which saw the expansion of telehealth services for people with substance use disorders, including opioid and alcohol use disorder.

    However, with each passing month, it appears the COVID-19 public health emergency (PHE) is more likely to come to an end, and along with it the waivers that have allowed providers in much of the country to write prescriptions for MAT such as buprenorphine with naloxone for opioid use disorders (OUDs)--a scenario referred to as the Telehealth Cliff.

    In this Episode, Nate and Sunny talk about the future of MAT, the importance of ePrescribing for SUDs and OUDs, pending legislation or rulemaking that could make virtual MAT permanent, and how the public can help influence upcoming decisions on ePrescribing policies.
    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Continued access to telehealth services, particularly as it relates to medication assisted treatment (MAT) for substance use disorders (SUDs), enjoys strong support and is an issue worth keeping an eye on. Nate Lacktman and Sunny Levine of the prestigious law firm of Foley & Lardner discuss the current state of telehealth regulations in the wake of COVID-19, which saw the expansion of telehealth services for people with substance use disorders, including opioid and alcohol use disorder.

However, with each passing month, it appears the COVID-19 public health emergency (PHE) is more likely to come to an end, and along with it the waivers that have allowed providers in much of the country to write prescriptions for MAT such as buprenorphine with naloxone for opioid use disorders (OUDs)--a scenario referred to as the Telehealth Cliff.

In this Episode, Nate and Sunny talk about the future of MAT, the importance of ePrescribing for SUDs and OUDs, pending legislation or rulemaking that could make virtual MAT permanent, and how the public can help influence upcoming decisions on ePrescribing policies.
続きを読む 一部表示

#10 Telehealth Regulations, Opioids, and Substance Use Treatmentに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。